期刊文献+

抗CD_3/抗TNP双功能抗体的制备及对胃癌细胞系的杀伤作用 被引量:1

Preparation of Anti CD_3/Anti TNP (BsAb) and Mediation of Cytotoxicity of MGC803
暂未订购
导出
摘要 :目的 以化学方法将抗CD3 及抗三硝基苯 (TNP)单克隆抗体交联为双功能抗体 ,研究此双功能抗体与任何TNP化的抗肿瘤单抗结合 ,介导对肿瘤细胞的杀伤作用。方法 分别纯化抗CD3 及抗TNP单克隆抗体 ,经二硫苏糖醇 (DTT)还原、偶联得到抗CD3 /抗TNP双抗。TNP化抗胃癌单抗PD4 、3H11与抗CD3 /抗TNP双抗介导人淋巴细胞对胃癌细胞系MGC80 3的细胞毒作用。结果 双抗与TNP化的单抗结合 ,介导效应细胞对靶细胞的杀伤率高于未TNP化单抗 ,并随着效靶比的提高而升高。结论 抗CD3 /抗TNP双抗能够与不同种类的TNP化单抗结合介导效应细胞杀伤靶细胞 。 Objective To prepare a bispecific antibody (BsAb) against CD3 and TNP and to test its cytotoxic effect against the gastric cancer cell line,MGC803.Methods In this study,the bispecific antibody was obtained from chemical crosslinked anti CD 3 McAb with anti TNP McAb.Using this bispecific McAb,human peripheral blood lymphocytes were induced to cytotoxic test of MGC803 tumour cells directed by different TNP McAb.Results BsAb combined with TNP McAb mediated cytotoxicity against MGC803 was much more effective than that combined with no TNP McAb.The cell lytic effect was proportional to the ratio of effecter cells to target cells.Conclusion Anti CD 3/Anti TNP with versatile adaptor could mediate different antibody that crosslinked with TNP,and has potential value in clinic.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2000年第2期84-85,共2页 Cancer Research on Prevention and Treatment
基金 北京市自然科学基金资助项目 !(7932 0 0 2 )
关键词 双功能抗体 三硝基苯 细胞毒作用 胃癌 Bispecific antibody TNP Cytotoxicity
  • 相关文献

参考文献3

  • 1王力民,高科技通讯,1993年,1卷,23页
  • 2卢良军,北京医科大学学报,1991年,23卷,6期,455页
  • 3万文徽,北京医学院学报,1984年,16卷,4期,278页

同被引文献11

  • 1曲群,彭慧霞,宗璐,赵玲,段钊,杜稳侠.双功能抗体抗CD3/抗CyclinD1的制备及对子宫内膜癌细胞的杀伤作用[J].第四军医大学学报,2004,25(18):1663-1665. 被引量:2
  • 2Lefterova P,Mrten A,Buttgereit P,et al.Targeting of natural killer-like T immunologic effector cells against leukemia and lymphoma cellsby reverse antibody-dependent cellular cytotoxicity[J].J Immunother,2000,23(3):304-310.
  • 3Tita-Nwa F,Moldenhauer G,Herbst M,et al.Cytokine-induced killercells targeted by the novel bispecific antibody CD19xCD5(HD37xT5.16)efficiently lyse B-lymphoma cells[J].Cancer Immunol Immu-nother,2007,56(12):1911-1920.
  • 4Chen Y,Yang SC,Luo H.A chermira antibody erythroimmunoassayfor detecting HBsAg in human sera[J].Res Virol,1990,141(3):337-339.
  • 5Alan W.Molecules in focus EGF receptor[J].Int J Biochem Cell Bi-ol,1999,31(6):637-643.
  • 6Reiter JL,Maihle NJ.A 1.8kb aleration transcript form the human ep-idermal groth factor gene encodes a truncated form of the receptor[J].Nucleic Acids Res,1996,24(20):4050-4056.
  • 7Baselga J.Why the epidermal growth factor receptor?The rational forcancer therapy[J].Oncologist,2002,7(4):2-8.
  • 8Herbst RS,Langer CJ.Epidermal growth factor receptors as a target forcancer treatment:the emerging role of IMC-C225 in the treatment oflung and head and neck cancer[J].Semin Oncol,2002,29(1):27-36.
  • 9Rusch V,Mendslsohn J,Dmitrovsky E.The epidermal growth factorreceptor and its ligind as therapeutic targets in human tumors[J].Cy-tokine Growth Factor Rev,1996,7(2):133-141.
  • 10Kornacker M,Verneris M,Kornacker B,et al.The apoptotic andproliferative fate of cytokine-induced killer cells after redirection totumor cells with bispecific Ab[J].Cytotherapy,2006,8(1):13-23.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部